Versigent PLC (VGNT)
NYSEConsumer DiscretionaryElectrical Equipment & PartsSnapshot 2026-11-04
$41.97+3.15%
Close 2026-11-04 · 1-day change
NYSEConsumer DiscretionaryElectrical Equipment & PartsSnapshot 2026-11-04
QuarterlyIQ Insights · VGNT
How strong the business is — where it ranks within its sector on capital efficiency and cash generation, and how well management has been executing.
How management runs the business: capital, margins, balance sheet, and how reliably they guide and deliver.
A guidance track record builds as the company issues and delivers on guidance.
Priorities management has stated in recent disclosures, with status and evidence drawn from earnings calls, filings, and press releases.
Highlights Third Quarter 2026 • Net sales of $2,450 million, up 7.2% year-over-year ◦ Adjusted Net Sales Growth 1 of approximately 1% year-over-year • Net income attributable to Versigent of $102 mil…
Stated in 1 of 3 supplied quarters. Management reported: “Adjusted Net Sales Growth 1 , which excludes the impact of year-over-year commodity and foreign currency movements, was approximately 1% despite lower global automotive production.” “Net income attributable to Versigent was $102 million, compared to $109 million in the prior-year quarter.”
Each factor is a parallel diagnostic with a clear read of what it shows and how names like it have historically fared. Never aggregated into a single score.
Not enough signal yet.
Not enough signal yet.
Most sensitive to the broad stock market.
Not enough signal to read sensitivity to the US dollar, real (inflation-adjusted) rates, long-term interest rates, Fed net liquidity (low R² over the window).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Highlights Third Quarter 2026 • Net sales of $2,450 million, up 7.2% year-over-year ◦ Adjusted Net Sales Growth 1 of approximately 1% year-over-year • Net income attributable to Versigent of $102 mil…”
Highlights Third Quarter 2026 • Net sales of $2,450 million, up 7.2% year-over-year ◦ Adjusted Net Sales Growth 1 of approximately 1% year-over-year • Net income attributable to Versigent of $102 mil…
Stated in 1 of 3 supplied quarters. Management reported: “Diluted EPS was $1.41 and Adjusted Diluted EPS 1 was $1.91 for the third quarter of 2026.” “The Company does not provide a reconciliation of such forward-looking measure to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP because to do so would be potentially misleading and not practical given the difficulty of projecting event-driven transactional and other non-core operating items in any future period.”
“Highlights Third Quarter 2026 • Net sales of $2,450 million, up 7.2% year-over-year ◦ Adjusted Net Sales Growth 1 of approximately 1% year-over-year • Net income attributable to Versigent of $102 mil…”
Highlights Third Quarter 2026 • Net sales of $2,450 million, up 7.2% year-over-year ◦ Adjusted Net Sales Growth 1 of approximately 1% year-over-year • Net income attributable to Versigent of $102 mil…
Stated in 2 of 3 supplied quarters. Management reported: “Interest expense was $36 million in the quarter, compared to de minimis for the third quarter of 2025, principally due to the Company’s senior notes and credit facility issued in the first quarter of 2026.” “In April 2026, Versigent’s board of directors approved a dividend policy, under which the Company intends to return a portion of future earnings to shareholders in the range of $0.13 per share quarterly, with the initial dividend expected to be declared at a future date.”
“Highlights Third Quarter 2026 • Net sales of $2,450 million, up 7.2% year-over-year ◦ Adjusted Net Sales Growth 1 of approximately 1% year-over-year • Net income attributable to Versigent of $102 mil…”
“In April 2026, Versigent’s board of directors approved a dividend policy, under which the Company intends to return a portion of future earnings to shareholders in the range of $0.13 per share quarte…”
Highlights Third Quarter 2026 • Net sales of $2,450 million, up 7.2% year-over-year ◦ Adjusted Net Sales Growth 1 of approximately 1% year-over-year • Net income attributable to Versigent of $102 mil…
Stated in 2 of 3 supplied quarters. Management reported: “Adjusted Net Sales Growth 1 , which excludes the impact of year-over-year commodity and foreign currency movements, was approximately 1% despite lower global automotive production.” “The Company does not provide a reconciliation of such forward-looking measure to the most directly comparable financial measure calculated and presented in accordance with U.S. GAAP because to do so would be potentially misleading and not practical given the difficulty of projecting event-driven transactional and other non-core operating items in any future period.”
“Highlights Third Quarter 2026 • Net sales of $2,450 million, up 7.2% year-over-year ◦ Adjusted Net Sales Growth 1 of approximately 1% year-over-year • Net income attributable to Versigent of $102 mil…”
“2026 Outlook Versigent reaffirmed its full-year 2026 financial guidance as follows: (in millions) Full-Year 2026 Revenue $9,100 - $9,400 U.S. GAAP net income $315 - $375 Adjusted EBITDA $950 - $1,030…”
6 material management or governance events in the past 24 months, led by M&A activity. Historically, Consumer Discretionary names rated neutral grew net income 53% of the time over the next year (vs 54% for the rest of the cohort, n=6802).
Not investment advice. As of 2026-11-04.